Hirosaki Lifescience Innovation is engaged in the development, manufacture, and sale of regenerative medicine products.
Hirosaki Lifescience Innovation has raised $15.2M in total funding. The most recent round was Series C. The last funding was announced in July 2024.
Hirosaki Lifescience Innovation's investors include Mitsubishi UFJ Capital, Fiducia, Nippon Venture Capital, Sumitomo Mitsui Trust Bank, 77 Capital.
Hirosaki Lifescience Innovation is headquartered in Aomori, Japan.
Hirosaki Lifescience Innovation is engaged in the development, manufacture, and sale of regenerative medicine products.
Hirosaki Lifescience Innovation is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hirosaki Lifescience Innovation — Funding & Investors." VCBacked, July 22, 2024, https://www.vcbacked.co/company/hirosaki-lifescience-innovation. Accessed November 12, 2026.
VCBacked. (2024). Hirosaki Lifescience Innovation — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/hirosaki-lifescience-innovation
{{cite web |title=Hirosaki Lifescience Innovation — Funding & Investors |url=https://www.vcbacked.co/company/hirosaki-lifescience-innovation |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Hirosaki Lifescience Innovation? Request a listing update